Search

Yuri K Peterson

from Charleston, SC
Age ~51
Get Report
Also known as:
Yuri Karl Peterson, Karl Peterson
Phone and address:
731 Leafwood Rd, Charleston, SC 29412
(843) 901-0192
Related to:
Yori K PetersonAllan M Garfinkel, 53Robert M Rush, 84Rita E Peterson, 82Joseph K Peterson, 84Jennifer R Peterson, 51Joop K Peterson, 72Brenda C Rush, 76Mary E Rush, 44
Connected to:
Aaron L Peterson, 44Ada W Peterson, 107Ahmad M Peterson, 49Alberto Peterson, 72Aldor C Peterson, 91Aleksandr L Peterson, 54Alex J Peterson, 47Alexandra Peterson, 51Alfred Peterson, 72Allison E Peterson, 58

Yuri Peterson Phones & Addresses

  • 731 Leafwood Rd, Charleston, SC 29412 (843) 901-0192
  • 146 Island Dr, Charleston, SC 29407 (843) 763-3216
  • James Island, SC
  • Durham, NC
  • 2001 Oak Creek Rd, New Orleans, LA 70123 (504) 733-0665
  • River Ridge, LA
  • Salem, WV

Resumes

Resumes

Yuri Peterson Photo 1

Research Associate Professor

View page
Location:
Charleston, SC
Industry:
Pharmaceuticals
Work:
The Medical University of South Carolina Department of Biomedical and Pharmaceutical Sciences since Feb 2009
Assistant Professor
Medical University of South Carolina Jun 2008 - Feb 2009
Research Assistant Professor
Duke University Medical Center 2004 - Jun 2008
Associate Researcher
LSU Health Sciences Center 2002 - 2004
Graduate Researcher
Medical University of South Carolina 1998 - 2002
Graduate Researcher
Education:
Louisiana State University Health Sciences Center 2001 - 2004
Ph.D., Molecular Pharmacology Medical University of South Carolina 1998 - 2001
MS, Cell and Molecular Pharmacology and Experimental Theraputics Salem International University 1992 - 1996
BS, Molecular Biology/Biotechnology
Skills:
Drug Discovery
Cell Culture
Cell Biology
Protein Chemistry
Cell
In Vitro
Pharmacology
Protein Purification
Microscopy
Cancer
Molecular Biology
Tissue Culture
Biochemistry
Western Blotting
Mass Spectrometry
Chromatography
Cell Signaling
Life Sciences
Signal Transduction
Biotechnology
Research
Protein Expression
Gel Electrophoresis
Assay Development
Lifesciences
Immunohistochemistry
Transfection
Immunology
Cell Based Assays
Qpcr
Rt Pcr
Confocal Microscopy
Animal Models
Immunofluorescence
Flow Cytometry
Cancer Research
In Vivo
Translational Research
Sequence Analysis
Fluorescence Microscopy
Bioinformatics
Sds Page
Stem Cells
Immunoprecipitation
Pcr
Languages:
Dutch
Yuri Peterson Photo 2

Yuri Peterson

View page
Yuri Peterson Photo 3

Yuri Peterson

View page

Publications

Us Patents

Methods For Inducing Mitochondrial Biogenesis

View page
US Patent:
20140024677, Jan 23, 2014
Filed:
Apr 9, 2013
Appl. No.:
13/859546
Inventors:
Craig C. BEESON - Mount Pleasant SC, US
Yuri K. PETERSON - James Island SC, US
Assignee:
MUSC Foundation For Research Development - Charleston SC
International Classification:
A61K 31/4704
A61K 31/138
A61K 31/137
US Classification:
514312, 514653, 514651
Abstract:
Methods and compositions for inducing mitochondrial biogenesis are provided. In some aspects, methods for the treatment of diseases such as acute kidney disease (AKI) or a muscle wasting disease by administering tomoxetine, nisoxetine, fenoterol, formoterol, or procaterol to an individual are provided.

Methods For Treating Glaucoma And Macular Degeneration

View page
US Patent:
20070249010, Oct 25, 2007
Filed:
Mar 12, 2007
Appl. No.:
11/716724
Inventors:
Vasantha Rao - Cary NC, US
Patrick Casey - Chapel Hill NC, US
Peifeng Deng - Chapel Hill NC, US
Yuri Peterson - Durham NC, US
Assignee:
Duke University - Durham NC
International Classification:
A61K 31/44
A61P 27/06
C12Q 1/02
US Classification:
435029000, 514341000
Abstract:
Inhibition of geranylgeranylation of Rho GTPases and heterotrimeric G-proteins in the aqueous outflow pathway increases aqueous humor outflow, possibly through the tissue relaxation, and through altered cell adhesive interactions and actin cytoskeletal organization in cells of the outflow pathway. In addition, such inhibition is useful for treating age-related macular degeneration. The GGTase-I enzyme is a molecular target for lowering increased ocular pressure in glaucoma patients.

Substituted Triazine Compounds And Uses Thereof

View page
US Patent:
20230101743, Mar 30, 2023
Filed:
Jan 6, 2021
Appl. No.:
17/790798
Inventors:
- Charleston SC, US
Juitung LIU - Sumter SC, US
Patrick M. WOSTER - Charleston SC, US
Yuri PETERSON - Charleston SC, US
Steven HOLSHOUSER - Charleston SC, US
Yu-Lin JIANG - Charleston SC, US
International Classification:
C07D 251/40
C07D 403/14
C07D 403/04
Abstract:
The present invention relates to compounds of formula (I): including any stereochemically isomeric form thereof, or pharmaceutically acceptable salts thereof, for the treatment of, for example, hypercholesterolemia.

5Ht1F Receptor Agonists And Mitochondrial Biogenesis

View page
US Patent:
20210238147, Aug 5, 2021
Filed:
Apr 23, 2021
Appl. No.:
17/238492
Inventors:
- Charleston SC, US
- Washington DC, US
Yuri Karl PETERSON - Charleston SC, US
Rick G. SCHNELLMANN - Tucson AZ, US
International Classification:
C07D 239/47
A61P 13/12
Abstract:
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, promote mitochondrial biogenesis and are useful for the treatment of, for example, acute kidney injury and chronic kidney disease.

5Ht1F Receptor Agonists And Mitochondrial Biogenesis

View page
US Patent:
20200055827, Feb 20, 2020
Filed:
Nov 2, 2017
Appl. No.:
16/347163
Inventors:
- Charleston SC, US
Craig C. BEESON - Charleston SC, US
Yuri Karl PETERSON - Charleston SC, US
Rick G. SCHNELLMANN - Tucson AZ, US
International Classification:
C07D 239/47
A61P 13/12
Abstract:
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, promote mitochondrial biogenesis and are useful for the treatment of, for example, acute kidney injury and chronic kidney disease.

Pyrazole Compounds, Compositions And Mehtods For Treatment Of Degenerative Diseases And Disorders

View page
US Patent:
20170121353, May 4, 2017
Filed:
Jan 17, 2017
Appl. No.:
15/407748
Inventors:
- Charleston SC, US
Christopher C. Lindsey - Wadmalaw Island SC, US
Yuri K. PETERSON - Charleston SC, US
Baerbel Rohrer - Charleston SC, US
International Classification:
C07F 7/08
C07D 401/14
C07D 403/06
C07D 401/04
Abstract:
Provided herein are compounds of the formula (I):as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of degenerative diseases and disorders.

Thiazole Compounds, Compositions And Methods For Treatment Of Degenerative Diseases And Disorders

View page
US Patent:
20160130241, May 12, 2016
Filed:
Jan 14, 2016
Appl. No.:
14/995803
Inventors:
- Charteston SC, US
Christopher C. LINDSEY - Wadmalaw Island SC, US
Yuri K. PETERSON - Charleston SC, US
Baerbel ROHRER - Charleston SC, US
International Classification:
C07D 277/56
C07D 417/04
Abstract:
Provided herein are compounds of the formula (I):as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of degenerative diseases and disorders.

Isatin Compounds, Compositions And Methods For Treatment Of Degenerative Diseases And Disorders

View page
US Patent:
20150218128, Aug 6, 2015
Filed:
Apr 14, 2015
Appl. No.:
14/685962
Inventors:
- Charleston SC, US
Christopher C. Lindsey - Wadmalaw Island SC, US
Yuri K. Peterson - Charleston SC, US
Baerbel Rohrer - Charleston SC, US
International Classification:
C07D 401/06
C07D 209/36
Abstract:
Provided herein are compounds of the formula (I):as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of degenerative diseases and disorders.
Control profile
Yuri K Peterson from Charleston, SC, age ~51 Get Report